Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Generation of cleidocranial dysplasia-specific human induced pluripotent stem cells in completely serum-, feeder-, and integration-free culture.
Yamasaki S, Hamada A, Akagi E, Nakatao H, Ohtaka M, Nishimura K, Nakanishi M, Toratani S, Okamoto T. Yamasaki S, et al. Among authors: ohtaka m. In Vitro Cell Dev Biol Anim. 2016 Feb;52(2):252-64. doi: 10.1007/s11626-015-9968-x. Epub 2015 Nov 11. In Vitro Cell Dev Biol Anim. 2016. PMID: 26559068 Free PMC article.
Targeted reversion of induced pluripotent stem cells from patients with human cleidocranial dysplasia improves bone regeneration in a rat calvarial bone defect model.
Saito A, Ooki A, Nakamura T, Onodera S, Hayashi K, Hasegawa D, Okudaira T, Watanabe K, Kato H, Onda T, Watanabe A, Kosaki K, Nishimura K, Ohtaka M, Nakanishi M, Sakamoto T, Yamaguchi A, Sueishi K, Azuma T. Saito A, et al. Among authors: ohtaka m. Stem Cell Res Ther. 2018 Jan 22;9(1):12. doi: 10.1186/s13287-017-0754-4. Stem Cell Res Ther. 2018. PMID: 29357927 Free PMC article.
Induction of Noonan syndrome-specific human-induced pluripotent stem cells under serum-, feeder-, and integration-free conditions.
Hamada A, Akagi E, Obayashi F, Yamasaki S, Koizumi K, Ohtaka M, Nishimura K, Nakanishi M, Toratani S, Okamoto T. Hamada A, et al. Among authors: ohtaka m. In Vitro Cell Dev Biol Anim. 2020 Dec;56(10):888-895. doi: 10.1007/s11626-020-00515-9. Epub 2020 Nov 2. In Vitro Cell Dev Biol Anim. 2020. PMID: 33140329 Free PMC article.
Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
Bueno C, Sardina JL, Di Stefano B, Romero-Moya D, Muñoz-López A, Ariza L, Chillón MC, Balanzategui A, Castaño J, Herreros A, Fraga MF, Fernández A, Granada I, Quintana-Bustamante O, Segovia JC, Nishimura K, Ohtaka M, Nakanishi M, Graf T, Menendez P. Bueno C, et al. Among authors: ohtaka m. Leukemia. 2016 Mar;30(3):674-82. doi: 10.1038/leu.2015.294. Epub 2015 Oct 26. Leukemia. 2016. PMID: 26500142
Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming.
Nishimura K, Sano M, Ohtaka M, Furuta B, Umemura Y, Nakajima Y, Ikehara Y, Kobayashi T, Segawa H, Takayasu S, Sato H, Motomura K, Uchida E, Kanayasu-Toyoda T, Asashima M, Nakauchi H, Yamaguchi T, Nakanishi M. Nishimura K, et al. Among authors: ohtaka m. J Biol Chem. 2011 Feb 11;286(6):4760-71. doi: 10.1074/jbc.M110.183780. Epub 2010 Dec 7. J Biol Chem. 2011. PMID: 21138846 Free PMC article.
Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation.
Nishimura T, Kaneko S, Kawana-Tachikawa A, Tajima Y, Goto H, Zhu D, Nakayama-Hosoya K, Iriguchi S, Uemura Y, Shimizu T, Takayama N, Yamada D, Nishimura K, Ohtaka M, Watanabe N, Takahashi S, Iwamoto A, Koseki H, Nakanishi M, Eto K, Nakauchi H. Nishimura T, et al. Among authors: ohtaka m. Cell Stem Cell. 2013 Jan 3;12(1):114-26. doi: 10.1016/j.stem.2012.11.002. Cell Stem Cell. 2013. PMID: 23290140 Free article.
179 results